Literature DB >> 347053

Targets of octopamine action in the lobster: cyclic nucleotide changes and physiological effects in hemolymph, heart and exoskeletal muscle.

B A Battelle, E A Kravitz.   

Abstract

We have examined three potential targets of octopamine action of the lobster--hemolymph, heart and exoskeletal muscle--and found that each tissue responds to the amine with increases in cyclic adenosine 3': 5'-monophosphate (cAMP) and changes in measurable physiological phenomena. A highly specific octopamine-stimulated increase in cAMP is observed in hemolymph, and this effect is probably due to the presence of a unique octopamine receptor on hematocytes. Pharmacological studies show that synephrine is a potent agonist of the hemolymph receptor for octopamine and that the alpha adrenergic receptor blockers phentolamine and dibenamine and the dopamine receptor blocker, chlorpromazine, are antagonists. Addition of octopamine to lobster hemolymph increases the rate of changes the nature of the clotting reaction. AMP levels in lobster heart are elevated by both octopamine and serotonin. Both amines also increase the rate and the amplitude of the heart beat. Octopamine, serotonin and dopamine all increase cAMP levels in lobster exoskeletal muscle preparations, and each amine causes changes in muscle tension and the strength of nerve evoked contractions. In none of the tissues studied have we been able to establish a direct relationship between amine-stimulated increases in cAMP levels and the physiological responses.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 347053

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  15 in total

1.  A voltage-sensitive cation channel present in clusters in lobster skeletal muscle membrane.

Authors:  M K Worden; R Rahamimoff; E A Kravitz
Journal:  J Membr Biol       Date:  1994-08       Impact factor: 1.843

2.  Dopaminergic modulation of neurosecretory cells in the crayfish.

Authors:  Ramón Alvarez Alvarado; Mercedes Graciela Porras Villalobos; Gabina Calderón Rosete; Leonardo Rodríguez Sosa; Hugo Aréchiga
Journal:  Cell Mol Neurobiol       Date:  2005-03       Impact factor: 5.046

3.  Motoneurons which may utilize dopamine as their neurotransmitter.

Authors:  J W Swann; C N Sinback; P R Kebabian; D O Carpenter
Journal:  Cell Mol Neurobiol       Date:  1982-12       Impact factor: 5.046

4.  Fluorometric determination of octopamine in tissue homogenates by high-performance liquid chromatography.

Authors:  L D Mell; D O Carpenter
Journal:  Neurochem Res       Date:  1980-10       Impact factor: 3.996

5.  The action of serotonin on excitatory nerve terminals in lobster nerve-muscle preparations.

Authors:  S Glusman; E A Kravitz
Journal:  J Physiol       Date:  1982-04       Impact factor: 5.182

6.  The peptide hormone pQDLDHVFLRFamide (crustacean myosuppressin) modulates the Homarus americanus cardiac neuromuscular system at multiple sites.

Authors:  J S Stevens; C R Cashman; C M Smith; K M Beale; D W Towle; A E Christie; P S Dickinson
Journal:  J Exp Biol       Date:  2009-12       Impact factor: 3.312

Review 7.  Trace amine-associated receptor 1-Family archetype or iconoclast?

Authors:  David K Grandy
Journal:  Pharmacol Ther       Date:  2007-07-17       Impact factor: 12.310

8.  Dopamine produces muscle contractions and modulates motoneuron-induced contractions in Aplysia gill.

Authors:  J W Swann; C N Sinback; M G Pierson; D O Carpenter
Journal:  Cell Mol Neurobiol       Date:  1982-12       Impact factor: 5.046

9.  Multiple receptor types for octopamine in the locust.

Authors:  P D Evans
Journal:  J Physiol       Date:  1981-09       Impact factor: 5.182

10.  Identification and developmental expression of the enzymes responsible for dopamine, histamine, octopamine and serotonin biosynthesis in the copepod crustacean Calanus finmarchicus.

Authors:  Andrew E Christie; Tiana M Fontanilla; Vittoria Roncalli; Matthew C Cieslak; Petra H Lenz
Journal:  Gen Comp Endocrinol       Date:  2013-10-19       Impact factor: 2.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.